Clinical activity of duvelisib (IPI-145), a phosphoinositide-3-kinase-δ,γ inhibitor, in patients previously treated with ibrutinib Meeting Abstract


Authors: Porcu, P.; Flinn, I.; Kahl, B. S.; Horwitz, S. M.; Oki, Y.; Byrd, J. C.; Sweeney, J.; Allen, K.; Faia, K.; Ni, M.; Stern, H. M.; Kelly, P.; O'Brien, S.
Abstract Title: Clinical activity of duvelisib (IPI-145), a phosphoinositide-3-kinase-δ,γ inhibitor, in patients previously treated with ibrutinib
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349233800028
PROVIDER: wos
DOI: 10.1182/blood.V124.21.3335.3335
Notes: Meeting Abstract: 3335 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    664 Horwitz